Literature DB >> 21245871

Visualization of cell death in mice with focal cerebral ischemia using fluorescent annexin A5, propidium iodide, and TUNEL staining.

Peyman Bahmani1, Eyk Schellenberger, Jan Klohs, Jens Steinbrink, Ryan Cordell, Marietta Zille, Jochen Müller, Denise Harhausen, Leo Hofstra, Chris Reutelingsperger, Tracy Deanne Farr, Ulrich Dirnagl, Andreas Wunder.   

Abstract

To monitor stroke-induced brain damage and assess neuroprotective therapies, specific imaging of cell death after cerebral ischemia in a noninvasive manner is highly desirable. Annexin A5 has been suggested as a marker for imaging cell death under various disease conditions including stroke. In this study, C57BL6/N mice received middle cerebral artery occlusion (MCAO) and were injected intravenously with either active or inactive Cy5.5-annexin A5 48 hours after reperfusion. Some mice also received propidium iodide (PI), a cell integrity marker. Only in mice receiving active Cy5.5-annexin A5 were fluorescence intensities significantly higher over the hemisphere ipsilateral to MCAO than on the contralateral side. This was detected noninvasively and ex vivo 4 and 8 hours after injection. The majority of cells positive for fluorescent annexin A5 were also positive for PI and fragmented DNA as detected by terminal deoxynucleotidyl transferase-mediated 2'-deoxyuridine 5'-triphosphate-biotin nick end labeling (TUNEL) staining. This study demonstrates the high specificity of annexin A5 for visualization of cell death in a mouse model of stroke. To our knowledge, this is the first study to compare the distribution of injected active and inactive annexin A5, PI, and TUNEL staining. It provides important information on the experimental and potential clinical applications of annexin A5-based imaging agents in stroke.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245871      PMCID: PMC3099638          DOI: 10.1038/jcbfm.2010.233

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  44 in total

1.  Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis.

Authors:  Bas L J H Kietselaer; Chris P M Reutelingsperger; Guido A K Heidendal; Mat J A P Daemen; Werner H Mess; Leonard Hofstra; Jagat Narula
Journal:  N Engl J Med       Date:  2004-04-01       Impact factor: 91.245

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

3.  Near-infrared fluorescent imaging of tumor apoptosis.

Authors:  Alexander Petrovsky; Eyk Schellenberger; Lee Josephson; Ralph Weissleder; Alexei Bogdanov
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging.

Authors:  Heidi Kenis; Harmen Reinier Zandbergen; Leonard Hofstra; Artiom D Petrov; Ewald A Dumont; Francis D Blankenberg; Nezam Haider; Nicole Bitsch; Marion Gijbels; Johan W H Verjans; Navneet Narula; Jagat Narula; Chris P M Reutelingsperger
Journal:  J Nucl Med       Date:  2010-02       Impact factor: 10.057

Review 5.  Monitoring of treatment-induced apoptosis in oncology with PET and SPECT.

Authors:  Francis G Blankenberg
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Evaluation of annexin V as a platelet-directed thrombus targeting agent.

Authors:  J F Tait; M D Cerqueira; T A Dewhurst; K Fujikawa; J L Ritchie; J R Stratton
Journal:  Thromb Res       Date:  1994-09-01       Impact factor: 3.944

7.  Monitoring the protective effects of minocycline treatment with radiolabeled annexin V in an experimental model of focal cerebral ischemia.

Authors:  Xian Nan Tang; Qing Wang; Maya A Koike; Danye Cheng; Michael L Goris; Francis G Blankenberg; Midori A Yenari
Journal:  J Nucl Med       Date:  2007-10-17       Impact factor: 10.057

8.  Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI.

Authors:  Eyk A Schellenberger; Alexei Bogdanov; Dagmar Högemann; Jonathan Tait; Ralph Weissleder; Lee Josephson
Journal:  Mol Imaging       Date:  2002 Apr-Jun       Impact factor: 4.488

Review 9.  Future contrast agents for molecular imaging in stroke.

Authors:  Stefan Heckl
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.

Authors:  Gerrit J Kemerink; Xuan Liu; Davy Kieffer; Sarah Ceyssens; Luc Mortelmans; Alfons M Verbruggen; Neil D Steinmetz; Jean-Luc Vanderheyden; Allan M Green; Kristin Verbeke
Journal:  J Nucl Med       Date:  2003-06       Impact factor: 10.057

View more
  20 in total

Review 1.  Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives.

Authors:  Marietta Zille; Tracy D Farr; Ingo Przesdzing; Jochen Müller; Clemens Sommer; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-16       Impact factor: 6.200

2.  A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.

Authors:  Marietta Zille; Denise Harhausen; Marijke De Saint-Hubert; Roger Michel; Chris P Reutelingsperger; Ulrich Dirnagl; Andreas Wunder
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-02       Impact factor: 6.200

3.  Effects of the combined treatment of bone marrow stromal cells with mild exercise and thyroid hormone on brain damage and apoptosis in a mouse focal cerebral ischemia model.

Authors:  Kobar Akhoundzadeh; Abedin Vakili; Hamid Reza Sameni; Abbas Ali Vafaei; Ali Rashidy-Pour; Manouchehr Safari; Razieh Mohammadkhani
Journal:  Metab Brain Dis       Date:  2017-05-25       Impact factor: 3.584

4.  Monitoring stroke progression: in vivo imaging of cortical perfusion, blood-brain barrier permeability and cellular damage in the rat photothrombosis model.

Authors:  Karl Schoknecht; Ofer Prager; Udi Vazana; Lyn Kamintsky; Denise Harhausen; Marietta Zille; Lena Figge; Yoash Chassidim; Eyk Schellenberger; Richard Kovács; Uwe Heinemann; Alon Friedman
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

5.  Imaging of rat cerebral ischemia-reperfusion injury using(99m)Tc-labeled duramycin.

Authors:  Yuqing Zhang; Gail D Stevenson; Christy Barber; Lars R Furenlid; Harrison H Barrett; James M Woolfenden; Ming Zhao; Zhonglin Liu
Journal:  Nucl Med Biol       Date:  2012-11-02       Impact factor: 2.408

6.  Multicolor fluorescence imaging of traumatic brain injury in a cryolesion mouse model.

Authors:  Bryan A Smith; Bang-Wen Xie; Ermond R van Beek; Ivo Que; Vicky Blankevoort; Shuzhang Xiao; Erin L Cole; Mathias Hoehn; Eric L Kaijzel; Clemens W G M Löwik; Bradley D Smith
Journal:  ACS Chem Neurosci       Date:  2012-04-07       Impact factor: 4.418

7.  Amyloid Precursor Protein Protects Neuronal Network Function after Hypoxia via Control of Voltage-Gated Calcium Channels.

Authors:  Dimitri Hefter; Martin Kaiser; Sascha W Weyer; Ismini E Papageorgiou; Martin Both; Oliver Kann; Ulrike C Müller; Andreas Draguhn
Journal:  J Neurosci       Date:  2016-08-10       Impact factor: 6.167

8.  The therapeutic effect of methotrexate-conjugated Pluronic-based polymeric micelles on the folate receptor-rich tumors treatment.

Authors:  Yanzuo Chen; Wei Zhang; YuKun Huang; Feng Gao; Xianyi Sha; Kaiyan Lou; Xiaoling Fang
Journal:  Int J Nanomedicine       Date:  2015-06-19

9.  Optical imaging to map blood-brain barrier leakage.

Authors:  Hayder Jaffer; Isaac M Adjei; Vinod Labhasetwar
Journal:  Sci Rep       Date:  2013-11-01       Impact factor: 4.379

10.  A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion.

Authors:  Helena W Morrison; Jessica A Filosa
Journal:  J Neuroinflammation       Date:  2013-01-11       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.